Quest Diagnostics Inc. again won dismissal of a class action brought by consumers claiming it monopolized the Northern California diagnostic labs market (Eastman v. Quest Diagnostics Inc., N.D. Cal., 3:15-cv-00415-WHO, dismissed 11/25/15).
The plaintiffs, who paid co-payments and deductibles on lab work done at Quest, alleged that Quest has monopolized and “substantially foreclosed competition” in two markets by paying kickbacks to doctors, by colluding with major private health insurers Blue Shield of California and Aetna and by acquiring competing labs in order to eliminate them as competitors.
Judge William H. Orrick of the U.S. District Court for ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.